BNP Paribas Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Buy
9,897
+2,488
+34% +$60.8K ﹤0.01% 1332
2025
Q4
$168K Buy
7,409
+2,092
+39% +$45.5K ﹤0.01% 1367
2025
Q3
$107K Sell
5,317
-17
-0.3% -$285 ﹤0.01% 839
2025
Q2
$76K Buy
+5,334
New +$62.3K ﹤0.01% 996
2023
Q2
Sell
-1,101,948
Closed -$10.4M 867
2023
Q1
$10.4M Buy
1,101,948
+38,255
+4% +$451K 0.04% 421
2022
Q4
$13M Buy
1,063,693
+450,787
+74% +$5.62M 0.05% 382
2022
Q3
$7.61M Buy
612,906
+158,655
+35% +$2.77M 0.03% 454
2022
Q2
$8.92M Buy
+454,251
New +$10.8M 0.03% 426
2019
Q4
Sell
-9,382
Closed -$249K 833
2019
Q3
$249K Buy
9,382
+1,511
+19% +$45.3K ﹤0.01% 813
2019
Q2
$266K Buy
+7,871
New +$256K ﹤0.01% 849

Other funds holding ELAN

BNP Paribas Asset Management's ELAN Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Elanco Animal Health (ELAN) stake by 34% in Q1 2026, buying an estimated $60.8K and bringing the position to 9,897 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1332.

BNP Paribas Asset Management first reported a position in ELAN in Q2 2019 and has held it in 10 quarters since. The position peaked at $13M in Q4 2022. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • BNP Paribas Asset Management held 9,897 shares of Elanco Animal Health worth $237K as of Q1 2026.
  • BNP Paribas Asset Management bought 2,488 Elanco Animal Health shares in Q1 2026, an estimated $60.8K.
  • Elanco Animal Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1332 holding.
  • BNP Paribas Asset Management first reported a position in Elanco Animal Health in Q2 2019 and has held it in 10 quarters since.
  • BNP Paribas Asset Management's Elanco Animal Health position peaked at $13M in Q4 2022.
  • 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.